Champions Oncology (CSBR) Minority Interest (2011 - 2026)

Champions Oncology (CSBR) recorded quarterly Minority Interest of $95000.0 in Q1 2026, up 55.74% quarter-over-quarter from $61000.0 in Q4 2025.

Champions Oncology (CSBR) Minority Interest (2011 - 2026) Analysis & Trends

Champions Oncology's Minority Interest history runs 5 years deep, the most recent figure standing at $95000.0 for Q1 2026.

In Q1 2026, Minority Interest changed N/A year-over-year to $95000.0; the TTM figure through Jan 2026 stood at $95000.0 (changed N/A YoY), while the FY2013 annual figure was $16.9 million, up 106.91% from the prior year.
Minority Interest was $95000.0 for Q1 2026 at Champions Oncology, up from $61000.0 in the prior quarter.
In the past five years, Minority Interest ranged from a high of $95000.0 in Q1 2026 to a low of $30000.0 in Q3 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Alterity Therapeutics	719,706.53 Bn	719,706.50 Bn	-
2	Belite Bio	55,800.00 Bn	55,800.00 Bn	-
3	Quantum Biopharma	18,182.30 Bn	18,182.29 Bn	-
4	Legend Biotech	3,154.00 Bn	3,153.71 Bn	242.10 Mn
5	Akari Therapeutics	1,844.30 Bn	1,844.29 Bn	-
6	Evaxion A	1,567.96 Bn	1,567.94 Bn	-
7	Psyence Biomedical	251.43 Bn	251.42 Bn	-
8	Vertex Pharmaceuticals	112.56 Bn	105.31 Bn	2.59 Bn
9	Abivax	94.37 Bn	94.37 Bn	-
10	Champions Oncology	78.46 Mn	71.46 Mn	13.89 Mn

Download Data